BR112014004738A2 - composição de glutationa reduzida e acetaminofeno e método de sua preparação - Google Patents
composição de glutationa reduzida e acetaminofeno e método de sua preparaçãoInfo
- Publication number
- BR112014004738A2 BR112014004738A2 BR112014004738A BR112014004738A BR112014004738A2 BR 112014004738 A2 BR112014004738 A2 BR 112014004738A2 BR 112014004738 A BR112014004738 A BR 112014004738A BR 112014004738 A BR112014004738 A BR 112014004738A BR 112014004738 A2 BR112014004738 A2 BR 112014004738A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- reduced glutathione
- acetaminophen composition
- acetaminophen
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
- B29B9/00—Making granules
- B29B9/12—Making granules characterised by structure or composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mechanical Engineering (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2012/078550 WO2014008648A1 (zh) | 2012-07-12 | 2012-07-12 | 一种还原型谷胱甘肽对乙酰氨基酚组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014004738A2 true BR112014004738A2 (pt) | 2017-03-21 |
Family
ID=49915324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014004738A BR112014004738A2 (pt) | 2012-07-12 | 2012-07-12 | composição de glutationa reduzida e acetaminofeno e método de sua preparação |
Country Status (6)
Country | Link |
---|---|
US (1) | US20140179615A1 (pt) |
EP (1) | EP2769717A4 (pt) |
AU (1) | AU2012385429B2 (pt) |
BR (1) | BR112014004738A2 (pt) |
RU (1) | RU2620340C2 (pt) |
WO (1) | WO2014008648A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019013228A2 (pt) * | 2017-01-20 | 2019-12-10 | Kaneka Corp | fertilizante granular contendo glutationa |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3676549A (en) * | 1970-09-30 | 1972-07-11 | Alza Corp | Administration of alkali metal salts of salicylamide |
NL8500724A (nl) * | 1985-03-13 | 1986-10-01 | Univ Groningen | Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan. |
US6896899B2 (en) * | 1996-12-31 | 2005-05-24 | Antioxidant Pharmaceuticals Corp. | Pharmaceutical preparations of glutathione and methods of administration thereof |
WO1998029101A1 (en) * | 1996-12-31 | 1998-07-09 | Antioxidant Pharmaceuticals Corporation | Pharmaceutical preparations of glutathione and methods of administration thereof |
AU4085201A (en) * | 2000-03-15 | 2001-09-24 | Imperial College Innovations Limited | Pharmaceutical composition |
US20020160991A1 (en) * | 2000-12-04 | 2002-10-31 | Liming Shao | Orally-bioavailable formulations of fentanyl and congeners thereof |
CN1164326C (zh) * | 2002-08-29 | 2004-09-01 | 黄华 | 还原型谷胱甘肽含片 |
SE526982C2 (sv) * | 2003-05-27 | 2005-11-29 | Sca Hygiene Prod Ab | Enskiktspolymermatrisfilm innefattande mjölksyraproducerande bakterier, framställning samt användning därav |
BRPI0912820A2 (pt) * | 2008-05-20 | 2015-10-13 | Neurogesx Inc | pró-fármacos de relação hepatoprotetora de acetaminofeno |
-
2012
- 2012-06-12 US US14/240,230 patent/US20140179615A1/en not_active Abandoned
- 2012-07-12 AU AU2012385429A patent/AU2012385429B2/en not_active Ceased
- 2012-07-12 BR BR112014004738A patent/BR112014004738A2/pt not_active Application Discontinuation
- 2012-07-12 EP EP12881084.3A patent/EP2769717A4/en not_active Withdrawn
- 2012-07-12 WO PCT/CN2012/078550 patent/WO2014008648A1/zh active Application Filing
- 2012-07-12 RU RU2014110668A patent/RU2620340C2/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2769717A4 (en) | 2015-05-27 |
EP2769717A1 (en) | 2014-08-27 |
US20140179615A1 (en) | 2014-06-26 |
RU2620340C2 (ru) | 2017-05-24 |
AU2012385429A1 (en) | 2014-03-13 |
WO2014008648A1 (zh) | 2014-01-16 |
AU2012385429B2 (en) | 2015-07-02 |
RU2014110668A (ru) | 2016-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2929031T5 (da) | Pcsk9-irna-sammensætninger og fremgangsmåder til anvendelse deraf | |
DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
BR112015003354A2 (pt) | composições e métodos de microcápsula | |
DK3238709T3 (da) | Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme | |
BR112014005744A2 (pt) | composições de peptídeo glucagon-like-2 e métodos para sua produção e utilização | |
BR112015003227A2 (pt) | processos de clicoconjugação e composições | |
DK3035849T3 (da) | Lægemiddeleluering til beskyttelse in vivo af biosensor-analysander | |
DK2739293T3 (da) | Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus | |
BR112014031820A2 (pt) | aduto de politioéter e composição | |
BR112015003838A2 (pt) | formulações de anticorpo e proteína | |
BR112013032426A2 (pt) | composições probióticas e métodos | |
DK2663864T3 (da) | Fremgangsmåde til at vurdere immundiversitet og anvendelse af denne | |
BR112014010450A2 (pt) | composição e método | |
BR112013014644A2 (pt) | composição farmacêutica e complexo | |
DK2917358T3 (da) | Sammensætninger og fremgangsmåder til biologisk fremstilling af fedtsyrederivater | |
CO6980141A1 (es) | Compuestos y composiciones de poliglicerilo catónicos | |
BR112013033149A2 (pt) | peça de vestuário e método de sua produção | |
BR112013022766A2 (pt) | método de administração de d-pirfenidona e kit | |
DK2627656T3 (da) | Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf | |
DK2661274T3 (da) | Sammensætninger og fremgangsmåder med aloepolysaccharider | |
FI20115607A0 (fi) | Juusto ja menetelmä sen valmistamiseksi | |
DK3175852T3 (da) | Difluorlactamsammensætninger til EP4-medierede osteorelaterede sygdomme og tilstande | |
FI20135866L (fi) | Mikrobiologinen keratiinin prosessointi | |
BR112014002804A2 (pt) | revestimento e método de preparação do mesmo | |
BR112014010860A2 (pt) | composição e método |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07C | Technical examination (opinion): republication [chapter 7.3 patent gazette] |
Free format text: O PRESENTE PEDIDO TEVE UMA NOTIFICACAO DE ANUENCIA SEM APRESENTACAO DE SUBSIDIOS (DESPACHO 7.5) PUBLICADA NA RPI NO 2502. |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |